![Pieter Wyckmans](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3154279/47372439-cf0c-48b1-8195-7135e8bdf48e/profile.png)
Pieter Wyckmans
Europe Guide 2024
Band 2 : Life Sciences: Domestic
Band 2
About
Provided by Pieter Wyckmans
Practice Areas
Pieter Wyckmans provides expert advice to companies and organizations active in the (bio-) pharmaceutical, biotech and smart devices sectors. Pieter Wyckmans advises multinationals, SMEs, spin-offs and start-ups in (strategic) transactions, intellectual property matters and regulatory affairs.
Pieter Wyckmans combines years of experience as an M&A and commercial transactions lawyer, with years of experience as in-house counsel of multinationals, particularly in the Life Sciences industry. As in-house counsel, Pieter Wyckmans grew accustomed to the (bio)pharmaceutical and biotech sector and conscious of the scientific, economic and regulatory challenges the industry faces. This understanding, combined with his hands-on approach and pragmatism, is strongly appreciated by his clients.
Career
Partner - Quinz | September 2011 - Present
External Legal Counsel (secondee) - UCB Pharma | January 2010 - August 2011
Senior Legal Counsel - GDF SUEZ | October 2008 - December 2009
Senior Legal Counsel - BASF Antwerpen NV | January 2006 - September 2008
Senior Associate - Loyens & Loeff | October 2002 - December 2005
Associate - Linklaters | October 2000 - September 2002
Professional Memberships
Member of the Brussels Bar.
Contributions
Latest contributions provided by Pieter Wyckmans
![Pieter Wyckmans](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://chambersandpartners.azureedge.net/practiceguides/Pictures/447/63920.jpg)
![Olivier Van Obberghen](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://chambersandpartners.azureedge.net/practiceguides/Pictures/447/63918.jpg)
![Amber Cockx](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://chambersandpartners.azureedge.net/practiceguides/Pictures/447/63922.jpg)
![Chaline Sempels](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://chambersandpartners.azureedge.net/practiceguides/Pictures/447/64208.jpg)
![Pieter Wyckmans](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://chambersandpartners.azureedge.net/practiceguides/Pictures/413/59088.jpg)
![Olivier Van Obberghen](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://chambersandpartners.azureedge.net/practiceguides/Pictures/413/59087.jpg)
![Michiel D’herde](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://chambersandpartners.azureedge.net/practiceguides/Pictures/413/59493.png)
Discover other Lawyers at
QUINZ
Belgium
![Bart Lintermans](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3217798/af21ecbf-ddd9-4465-9440-71f13e0799f2/profile.png)
![Klaas Thibaut](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3217755/a3e6f877-b9b4-422d-ac2e-8c51339a7d08/profile.png)
![Wout Hooyberghs](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3217860/f92c3792-8ee7-4832-96da-8cf2df8cbe27/profile.png)
![Olivier Van Obberghen](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3154274/aa6d1a92-dadf-4f72-addc-f841c1b7210f/profile.png)
![Pieter Wyckmans](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3154279/47372439-cf0c-48b1-8195-7135e8bdf48e/profile.png)
![Marion Lapage](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3274480/f1f9639b-a212-4747-bcfa-7dccc1cd0b1b/profile.png)